REGISTERED NUMBER: 04469518 (England and Wales)

PHARMACY CONSULTING LIMITED

Unaudited Financial Statements for the Year Ended 31st March 2026

Page

Company Information

1

Balance Sheet

2

to

3

Notes to the Financial Statements

4

to

6

DIRECTOR:

Mrs Jacqueline Anne Peck

SECRETARY:

Mrs Jacqueline Anne Peck

REGISTERED OFFICE:

Wellesley House

10 Eelmoor Road

Farnborough

Hampshire

GU14 7QN

REGISTERED NUMBER:

04469518 (England and Wales)

ACCOUNTANTS:

TG Associates Limited

Chartered Accountants

7 Jardine House

Harrovian Business Village

Bessborough Road

Harrow

Middlesex

HA1 3EX

FIXED ASSETS

Tangible assets

4

13,390

16,737

Investments

5

50,000

-

63,390

16,737

CURRENT ASSETS

Debtors

6

872,305

1,016,401

Cash at bank

791,777

761,581

1,664,082

1,777,982

CREDITORS

Amounts falling due within one year

7

(119,705

)

(219,833

)

NET CURRENT ASSETS

1,544,377

1,558,149

TOTAL ASSETS LESS CURRENT LIABILITIES

1,607,767

1,574,886

CAPITAL AND RESERVES

Called up share capital

1

1

Retained earnings

1,607,766

1,574,885

1,607,767

1,574,886

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1st October 2026 and were signed by:

Mrs Jacqueline Anne Peck - Director

1.	STATUTORY INFORMATION

Pharmacy Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

20% on reducing balance

Computer equipment

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2025 - 11 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1st April 2025

and 31st March 2026

3,600

27,480

31,080

DEPRECIATION

At 1st April 2025

1,757

12,586

14,343

Charge for year

368

2,979

3,347

At 31st March 2026

2,125

15,565

17,690

NET BOOK VALUE

At 31st March 2026

1,475

11,915

13,390

At 31st March 2025

1,843

14,894

16,737

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

Additions

50,000

At 31st March 2026

50,000

NET BOOK VALUE

At 31st March 2026

50,000

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade debtors

109,808

223,059

Other debtors

762,497

793,342

872,305

1,016,401

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade creditors

24,870

23,984

Taxation and social security

87,110

152,599

Other creditors

7,725

43,250

119,705

219,833

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Mrs Jacqueline Anne Peck.